key: cord-0695412-b835h4ji
authors: Doroshenko, Alexander; Lee, Nelson; MacDonald, Clayton; Zelyas, Nathan; Asadi, Leyla; Kanji, Jamil N.
title: Decline of Influenza and Respiratory Viruses With COVID-19 Public Health Measures: Alberta, Canada
date: 2021-09-20
journal: Mayo Clin Proc
DOI: 10.1016/j.mayocp.2021.09.004
sha: c3d46e1d8e5987a83687f2f3f2801e824b77db5d
doc_id: 695412
cord_uid: b835h4ji

OBJECTIVE We evaluated the incidence of influenza and non-influenza respiratory viruses (NIRVs) pre-/post-implementation of public health (PH) measures aimed to decrease COVID-19 transmission using population-based surveillance data. We hypothesized that such measures could reduce the burden of respiratory viruses (RVs) transmitting via the same routes. PATIENTS AND METHODS An interrupted time-series analysis of RV surveillance data in Alberta, Canada from May 2017 – July 2020 was conducted. The burden of influenza and NIRVs before and after intervention initiation at week 11, 2020 was compared. The analysis was adjusted for seasonality, over-dispersion, and autocorrelation. RESULTS During the study period, an average of 708 and 4056 weekly respiratory multiplex molecular panels were conducted pre-/post-intervention respectively. We found significant reductions in test positivity rates in the post-intervention period for influenza (-94.3%; 95% CI -93.8 to 97.4%, p<0.001) and all NIRVs (-76.5%; 95% CI -77.3 to -75.8%, p<0.001) in the crude model, and -86.2% (95% CI -91.5 to -77.4%, p<0.001) and -75% (95% CI -79.7 to -69.3%, p<0.001) respectively, in the adjusted models. Sub-analyses for individual viruses demonstrated significant decreases in respiratory syncytial virus, human metapneumovirus, enterovirus/rhinovirus, and parainfluenza. For non-SARS-CoV-2 human coronaviruses, the decline was not statistically significant after adjustment (-22.3%; 95% CI -49.3 to +19%, p=0.246). CONCLUSION The implementation of COVID-19 PH measures likely resulted in reduced transmission of common RVs. While drastic lockdowns are unlikely to be required given widespread COVID-19 vaccination, targeted implementation of such measures can lower RV disease burden. Studies to evaluate relative contributions of individual interventions are warranted.

As of July 16, 2021, 188,655 ,968 confirmed cases of COVID-19, including 4,067,517 deaths, have been reported to the World Health Organisation (WHO). 1 Canada has reported 1,423,177 cases (including 26,499 deaths), with the province of Alberta (population 4.4 million) reporting 232,676 cases and 2,314 deaths. [2] [3] [4] The first case of COVID-19 in Canada was diagnosed on January 25, 2020 (epidemiological week 5) in Toronto, Ontario, with Alberta confirming its first case on March 5, 2020 (week 10). 5, 6 With the declaration of COVID-19 as a global pandemic on March 11, 2020 (week 11), a bundle of public health measures were immediately adopted by the Alberta Government to limit community spread. 7

This included closure of all pre-school to university in-person classes, bans on gatherings of more than 50 people, cessation to in-person restaurant dining, as well as closures of fitness centers, museums, children's play centers, playgrounds, child-minding facilities, bars, nightclubs, bingo centers, casinos, and public recreation centers and arenas. 7 Public Health authorities also promoted a physical distancing campaign which advised staying at home if possible, working from home, minimizing social activities outside immediate household circles, vigilance in monitoring for potential symptoms, and self-quarantine if one developed any symptoms. COVID-19 testing was provided freely via local public health departments. 4 Testing was initially for symptomatic patients only but expanded to widespread asymptomatic testing on April 23, 2020. 4 As shown in other jurisdictions, 8, 9 these interventions likely have contributed to the decrease in incidence of COVID-19 in Alberta during the first wave, thus 'flattening of the curve'. 10 The occurrence of the COVID-19 pandemic in Alberta and the implementation of public health interventions temporally coincided with the seasonal activities of influenza, respiratory syncytial virus (RSV), and other respiratory viral infections, which typically last until week 18 or beyond. 11 In Alberta, a province-wide laboratory surveillance program for all influenza and non-influenza respiratory viruses (NIRVs) diagnosed by multiplex polymerase chain reaction (PCR) assays was started in 2016; with weekly reports made available to the public online. 12 Through monitoring of our surveillance data, a sharp drop in the incidence of influenza infection was noticed after week 11. Sentinel surveillance data from northern and southern hemispheres have similarly described a substantial decrease in influenza transmission during this pandemic. [13] [14] [15] [16] [17] [18] [19] [20] In this analysis, we aim to study the incidence of influenza, as well as five common NIRVs pre-and post-initiation of public health interventions using our population-based surveillance data. Emerging evidence strongly indicates that the burden of NIRVs could be comparable to that of influenza. 21 We hypothesize that public health measures that aim to decrease COVID-19 transmission through droplets and close contact could simultaneously reduce the burden of other respiratory viruses transmitted via the same routes. Such data may have important implications for healthcare planning in the northern hemisphere during future respiratory virus seasons.

An interrupted time-series analysis was conducted using population-based respiratory virus surveillance data in Alberta, Canada from May 2017 to July 2020, covering three winter seasons. In Alberta, all data on virologic testing for acute respiratory infections are centralized by the Public Health Laboratory for surveillance reporting. In acute hospital and continuing care settings, respiratory samples collected from symptomatic individuals (with the aim to guide isolation precautions and clinical management) are subjected to multiplex-PCR testing for a panel of respiratory viruses. This includes influenza A (with H1-pdm09 and H3 subtypes) and B viruses; respiratory syncytial viruses A and B (RSV); human coronaviruses (hCoV-HKU1, 229E, OC43, NL63); human metapneumoviruses (hMPV); human entero/rhinoviruses (hERV), parainfluenza viruses (PIV 1-4) and adenovirus (AdV).

Details on sample processing, laboratory methods, and the assays' analytical performance have been described. 22 Multiplex respiratory virus testing was not conducted on asymptomatic individuals. In community settings, PCR-based testing for influenza A and B were performed pre-pandemic using an influenza-only PCR with multiplex respiratory viral panel PCR testing implemented from January-March 2020 as part of the pandemic response. 23 Data for this study, including virological results and testing time, during the period from week 19, 2017 to week 30, 2020 was extracted from the laboratory's information system and only anonymous data were analyzed.

To construct the weekly time series, the count of positive tests and the total number of tests performed each week during the study period were used to calculate the test positivity rate (TPR) for influenza and NIRVs. TPR as an indicator, intrinsically adjusts for the volume of tests performed, and the trend in the TPR is widely considered by public health authorities as a predictor of the extent of community transmission as well has been used in similar analyses from other judistrictions. [24] [25] [26] [27] [28] To test our hypothesis and evaluate the impact of pandemic public health measures on incidence of laboratory confirmed influenza and NIRV infections, we conducted interrupted time series (ITS) analysis using level change impact models as described by Bernal et al. 29 ITS with level change model was deemed the most appropriate statistical method as there was a clearly defined time of initiation of interventions at week 11 of 2020, thus separating the pre-and post-intervention periods.

We created the variable T denoting the time elapsed from the start of the study period with the unit representing weekly frequency of observations in time series, and variable Xt indicating the pre-intervention period (coded as 0) and the post-intervention period (coded as 1). The dependent outcome variable Yt denoted the incidence of respiratory viruses in preand post-intervention periods. In Poisson regression, the incidence rate (Yt specified as a parameter µ) is determined as a set of regressor variables (X and T). The segmented regression analysis we used can be expressed as:

We used log-transformed number of tests as an offset term in the model. We examined histograms/density plots of the untransformed and log-transformed test variables (Supplemental Figure 1) . Incidence-rate ratios (IRRs) (which refers to the change in the TPR for each virus in relation to the time of the intervention) and 95% confidence intervals (CIs) were derived from the Poisson model to characterize the impact of the intervention (Xt) on dependent variable Yt. We fitted separate models for the most common respiratory viruses, including influenza, RSV, hCoVs, hMPV, hERV and PIV. We first fitted the crude models and generated predicted values in order to create a plot of the model. We then generated the counterfactuals by removing the effect of interventions using the formula -p1 =p/exp(β[intervention]). The models were then adjusted for both overdispersion and seasonality. To adjust for seasonality, we used Fourier terms (pairs of sine and cosine functions). We examined the autocorrelation and partial autocorrelation plots of residuals from the predicted models. To correct for the weak-to-moderate residual autocorrelation, we computed Newey-West standard errors and corresponding confidence intervals for the seasonally-adjusted models. 30 Finally, on the seasonally adjusted graph we plotted a line as if all weeks were the average to produce a deseasonalized trend. To assess for influence of age on the testing results, the model was specifically run using respiratory testing results from patients aged 0-5 years, 0-16 years, and all ages (as many respiratory viruses commonly occur in those aged 0-5 years). 31, 32 The average virus-specific incidence rate per 100,000 people was also plotted for those aged 0-5 years, 0-16 years, and all ages. For the purposes of healthcare delivery, individuals aged ≥16 years are considered adults in Alberta.

All analyses were performed using Stata 14.2 software (StataCorp LP, 2015, College Station, TX, USA). The Stata code for the performed analyses is available in Supplemental Methods.

During the three-year study period, 185,978 multiplex-PCR tests were performed, For influenza (A and B), the cumulative TPR was 17.1% during the preintervention and 0.97% in the post-intervention periods respectively. The cumulative TPRs for RSV, hCoVs, hMPV, hERV and PIV were 6.99%, 3.78%, 4.2%, 15.8% and 4.4% respectively in the pre-intervention, and 0.55%, 1.2%, 1.06%, 3.88% and 0.31% respectively in the post-intervention periods. The mean weekly TPRs for these infections during the periods are reported in Table 1 . The corresponding test volumes and TPR for SARS-CoV-2 testing carried out from March 2020 -July 2020 is shown in Supplemental IRRswere calculated ( Table 2) . We found significant reductions in the TPRs in the post-intervention period for influenza of -94.3% (95% CI -93.8 to -94.7%, p<.001) and all NIRVs of -76.5% (95% CI -77.3 to -75.8%, p<.001) as shown in the crude model, and -86.2% (95% CI -91.5% to -77.4%, p<.001) and -75% (95% CI -79.7% to -69.3%, p<.001) respectively, in the adjusted model (for seasonality and over-dispersion). Results for individual NIRVs, including RSV, hMPV, hERV and PIV also demonstrated statistically significant declines in both the crude and the adjusted models ( Table 2) . By examining autocorrelation function, we found a weak-to-moderate autocorrelation for the above viruses, mostly at lags 1 to 4; however, computed Newey-West standard errors and corresponding CIs to correct for autocorrelation did not change the direction, or statistical significance of the models' predictions for most viruses (autocorrelograms and partial autocorrelograms are provided in Supplemental Figures 4 and 5) . We observed significant change in the trajectory of the time series of these viruses post -intervention compared with counterfactuals pre-intervention (Figures 2 and 3) .

The analyses concerning hCoVs demonstrated mixed results. There was a -67.8% (95% CI -64.7 to -70.5%, p<.001) reduction in the crude model, which was less pronounced when adjusted for seasonality and overdispersion (-22.3%; 95% CI -1.1 to -39%, p=.04), which became statistically non-significant after autocorrelation adjustment (95% CI -49.3% to 19.0%, p=.25) (Table 2 and Figure 3B ).

To evaluate the effect of patient age, the IRRs of TPR changes were compared between age groups 0-5 and 0-16 years (Supplemental Tables 1 and 2). Comparison of these two age groups demonstrated a non-significant reduction in hCoVs (as seen with all ages; Table 2) and hMPV (not seen among all ages). Based on this, age was not an influencing factor, but rather an effect modifier, in the reduction of respiratory virus activity (influenza and NIRVs) observed post-intervention.

Using our population-based surveillance data, we are able to show that the TPRs of influenza and NIRVs rapidly declined during the COVID-19 pandemic and was temporally Non-pharmacological interventions including physical distancing, isolation of symptomatic individuals, contact tracing, school closures, and use of face masks have been showed to be moderately effective for control of influenza epidemics and pandemics. 20 Our study adds that the burden of NIRVs was also significantly reduced, and that initiation of public health interventions is temporally correlated with their abrupt decline, suggesting effectiveness. At the time of writing, Australia also reports decrease in NIRV positivity rates which coincided with the implementation of COVID-19 control measures; with 10-fold or greater reductions in incidence of influenza, rhinovirus, RSV and PIV. 34 Further study is required to evaluate the effectiveness and relative importance of these non-pharmacological interventions to mitigate influenza and NIRV epidemics, and if any potential rebound effects (e.g. viral outbreaks) post lifting of stringent public health measures may occur, which has been described with RSV, hCoVs, and PIV. 40, 41 Nevertheless, our findings, together with data elsewhere strongly suggest that if public health measures were continued, the burden of other respiratory viral infections could be reduced, thus lowering the impacts on healthcare systems and public health. If adherence to public health measures is suboptimal or such measures are rolled back, then a rise in SARS-CoV-2, and other respiratory viruses would be expected.

Importantly, our data do not undermine the need for influenza vaccination, which is an effective means to reduce disease burden and hospitalizations. 42 Interestingly, we did not find a significant reduction of hCoVs in the post-intervention period as for other NRIVs. There is a paucity of data on hCoVs transmission; recent studies support the respiratory droplets and contact routes, with efficient transmission within households, and community activities generally follow a seasonal pattern. 43, 44 Our finding of low level hCoV circulation, despite significant reductions of influenza and other NIRVs, has also been noted from NIRV surveillance data from other countries (Canada, USA, and Switzerland for example). 45-47 From US and Swiss surveillance data, the most common hCoV subtypes seen during the COVID-19 pandemic include hCoV-NL63 and hCoV-OC43. The explanation for their low-level co-circulation with the pandemic virus despite public health measures is unclear, and further studies on their transmission characteristics (e.g., asymptomatic or presymptomatic transmission, as described for SARS-CoV-2), ecological fitness, and potential virus-virus interactions are required. 44 The strengths of our study include the large number of testing observations contributing to a robust data set. As the data regarding all respiratory virus testing is collected via a provincial population-based surveillance program, the data set encompasses results across all ages (including children) as well as both ambulatory and hospital-based settings. All influenza and NIRV infections were laboratory-confirmed. Our multiplex PCR assay did not differentiate between rhinoviruses and enteroviruses; however, enterovirus circulation was likely very low during the post-intervention period (winter/spring months in Alberta) with multiple jurisdictions having identified most pandemic circulating hERVs to be rhinovirus. 17, 48 The clearly defined initiation date of interventions in Alberta allowed the use of ITS to examine temporal correlations, and potential confounders including seasonality and over-dispersion were carefully adjusted in our models. We consider it unlikely that the increase in respiratory virus testing during the pandemic had resulted in lower positivity rates, as test opportunities are also increased for individuals with mild influenza-like illness who prior to the pandemic, may not have sought testing right away and monitored for self-improvement prior to seeking medical attention. Further, the impact of the volume of tests had been adjusted by comparing the TPR rather than the number of positive detections. The reduction in TPRs seen before and after the interventions are unlikely the result of qualitatively different populations being tested. This is justified by the fact that firstly, respiratory virus testing was performed on symptomatic individuals only. Secondly, the age stratification evaluation (comparison of IRRs and incidence rates in those aged 0-5 years, 0-16 years, and all ages) did not show paradoxical changes in respiratory virus categories. Thirdly, if influenza and/or NIRVs transmission rates held the same, the TPR for other viruses would have increased rather than decreased, which is the opposite of what was observed. Thus, it is likely that the intervention was successful at decreasing transmission of NIRVs as well.

Our study is limited by its observational natureand that interventions were bundled, thus the contribution of each individual measure (for instance, social distancing, selfquarantine, increased hand hygiene, use of masks) and changes in population behaviours cannot be discerned. The effect seen due to the intervention is suggestive of a correlation rather than direct causation, as not all variables could be controlled. The model used in this study did not adjust for viral co-infections (found to be very low, approximately 3%) 49 , as well as the effect of influenza vaccination. In Alberta, influenza vaccination coverage was constant, at approximately 30% over the study period, and the annual effectiveness was largely comparable for these years. 50, 51 Our study period did not include the time period from August 2020, at which universal masking was mandated in the two most populous cities in our province, Edmonton, and Calgary, which, combined, comprise approximately 50% of the province's population. 3 The role of travel restrictions was not specifically evaluated, however there were federal/national advisories in place to avoid non-essential travel and self-14-day quarantine post-international travel. 52 While there is no specific data regarding adherence to public health measures during the first wave in Alberta, a review by the Canadian Public Health Association highlighted that Canada was successful in flattening the curve of the first-wave of the COVID-19 pandemic. 53

In summary, implementation of public health interventions to mitigate the impact of COVID-19 was found to be associated with a substantial reduction in influenza and 

This study was investigator-initiated and received no funding support. Ethical approval for data collection and extraction was obtained from the Human Research Ethics Board (University of Alberta; study identifier Pro00100543).

This study was investigator-initiated and required no funding support. This work did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

None of the authors declare any competing interests with regards to this publication. All authors have completed the ICMJE form. The authors affirm that this manuscript is an honest, accurate, and transparent account of the study being reported. No important aspects of this study have been omitted. Any discrepancies from this study as originally planned have been fully explained.

Alexander Doroshenko -Data curation, formal analysis, methodology, project administration, software, validation, writing of original draft, and review of manuscript. 

None. Abbreviations: SDstandard deviation.

J o u r n a l P r e -p r o o f 

Public Health Measures: Alberta, Canada 2. Figure 1 (A-B) : Histogram/density plots of the test variable and log-transformed logtest variable.

3. Table 1 . Incidence Rate ratios (RRs) a and confidence intervals of the change in the test positivity rates for influenza and non-influenza respiratory viruses, before and after the initiation of COVID-19 pandemic public health interventions at week 11, 2020 among children 0-5 years old. c Adjustment for autocorrelation was performed by computing Newey-West standard errors (and corresponding 95% confidence intervals) on seasonally-adjusted models.

Coronavirus disease (COVID-19) pandemic. Vol 20202020. 2. Government of Canada. Coronavirus disease (COVID-19): Outbreak update.2020. 3. Government of Alberta. Population statistics2020. 4. Government of Alberta. COVID-19 info for Albertans

First imported case of 2019 novel coronavirus in Canada, presenting as mild pneumonia

First hospitalized case of laboratory-confirmed coronavirus infectious disease 2019 (COVID-19) in Alberta

Evaluation of the lockdowns for the SARS-CoV-2 epidemic in Italy and Spain after one month follow up

Flattening the COVID-19 Curve: The Impact of Contact Restrictions on the Infection Curve in Germany

Physical distancing interventions and incidence of coronavirus disease 2019: natural experiment in 149 countries

Seasonal Influenza Activity During the SARS-CoV-2 Outbreak in Japan

Decreased Influenza Incidence under COVID-19 Control Measures

Impact of Public Health Interventions on Seasonal Influenza Activity During the SARS-CoV-2 Outbreak in Korea

COVID-19 preventive measures showing an 1. year

interv (0 -pre-intervention period, 1-post-intervention period)

flurpp (count of weekly positive influenza A and B tests)

Supplementary Methods. Stata code used for analysis of surveillance data in this manuscript. Analyses performed separately for each group for respiratory viruses.Example below shows the Stata code for analysis of influenza viruses (variable name "flurpp").